|
Volumn 120, Issue 6, 2004, Pages 25-27
|
An experimental substantiation for using the "Semax" neuroprotector in the treatment of optic-nerve diseases;Eksperimental'noe obosnovanie ispol'zovaniia neiroprotektora semaksa v lechenii zabolevanii zritel'nogo nerva.
a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACTH (4 7), PRO GLY PRO;
ACTH (4-7), PRO-GLY-PRO-;
CORTICOTROPIN;
DRUG DERIVATIVE;
NEUROPROTECTIVE AGENT;
PEPTIDE FRAGMENT;
ANIMAL;
ARTICLE;
BRAIN CORTEX;
CHEMISTRY;
DISEASE MODEL;
ELECTROPHORESIS;
EYE;
INTRANASAL DRUG ADMINISTRATION;
LIQUID CHROMATOGRAPHY;
MALE;
METABOLISM;
OPTIC NERVE DISEASE;
RAT;
ADMINISTRATION, INTRANASAL;
ADRENOCORTICOTROPIC HORMONE;
ANIMALS;
CEREBRAL CORTEX;
CHROMATOGRAPHY, LIQUID;
DISEASE MODELS, ANIMAL;
ELECTROPHORESIS;
EYE;
MALE;
NEUROPROTECTIVE AGENTS;
OPTIC NERVE DISEASES;
PEPTIDE FRAGMENTS;
RATS;
|
EID: 14844312059
PISSN: 0042465X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|